Maternal Brain Imaging in Opioid Use Disorder
Key facts
- Who runs it
- Indiana University
- Where
- Indianapolis, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 45 people enrolled
- Started
- 15 Aug 2023
- Ended
- 31 Oct 2025
- Type of study
- Observational, 2 groups
- Treatments tested
- Buprenorphine
- Maternal Brain MRI
- Blood Samples
- Questionnaires
- Record updated
- 22 May 2026
Who can take part
- Age
- 18 years to 100 years
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Age: >18 years old
- Any subject that is currently on Buprenorphine at time of screening
- Singleton pregnancy
Who cannot take part
- Serious maternal medical illness
- HIV or AIDs
- Known or suspected major fetal congenital abnormalities; Pregnant Women with no history of OUD; Inclusion:
- Serious maternal medical illness
- HIV or AIDS
- Age: >18 years old
- Polysubstance use
- Score >9 on the PHQ-9, and score >0 on item 9 which is about suicidality
- Score of 8 or more on GAD-7
- Any contraindications for MRI
- Singleton pregnancy; Exclusion:
- Score of >9 on the PHQ-9, and a score of >0 on item 9 which is about suicidality
- Score of 8 or more on GAD-7
- Known or suspected major fetal congenital abnormalities
- Any contraindications for MRI
- Opioid or polysubstance abuse as identified on urine screening
Other criteria
- Pregnant Women with OUD
Where in United States
- Riley Hospital for ChildrenIndianapolis, United States
About the trial
What the trial wants to find out
This research study aims to learn more about opioid use disorder (OUD) during pregnancy and how outcomes for pregnant women and their newborns can be improved. During pregnancy, people with OUD are prescribed medication-assisted therapy (MAT). The investigators are interested to know how the medication is broken down by the body during pregnancy and how effective it is. The investigators also want to learn if this medication and OUD have any effect on the different parts of the brain when compared to mothers without OUD.
The 2 groups in the trial
- Pregnant Mothers with Opioid Use Disorder
Planned recruitment of 20 mothers with Opioid Use Disorder who are on Buprenorphine at the time of screening.
Treatment: Buprenorphine, Maternal Brain MRI, Blood Samples, and Questionnaires
- Pregnant Mothers
Planned recruitment of 20 mothers who do not have any history of opioid use disorder.
Treatment: Maternal Brain MRI and Questionnaires
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 22 May 2026